A shared study finding tracks GLP-1 receptor agonist prescriptions among adolescents who qualified for weight loss surgery from 2017 to 2025.
Recap by typeshit. Post by Facebook on Facebook.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
A Facebook post says rapid weight loss on these drugs can raise gallstone risk, and lists warning signs like severe upper belly pain, fever and yellow eyes.
TheStreet looks at what that means for patients paying up to $1,500 a month for peptide therapy and how the ruling could affect what they pay.
Loading…